- Home
- ACHV vs STRS Comparison
ACHV vs STRS Comparison
Compare ACHV & STRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- STRS
- Stock Information
- Founded
- ACHV N/A
- STRS 1992
- Country
- ACHV United States
- STRS United States
- Employees
- ACHV N/A
- STRS N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- STRS Homebuilding
- Sector
- ACHV Health Care
- STRS Real Estate
- Exchange
- ACHV Nasdaq
- STRS Nasdaq
- Market Cap
- ACHV 131.2M
- STRS 155.7M
- IPO Year
- ACHV N/A
- STRS N/A
- Fundamental
- Price
- ACHV $2.55
- STRS $17.30
- Analyst Decision
- ACHV Strong Buy
- STRS
- Analyst Count
- ACHV 3
- STRS 0
- Target Price
- ACHV $14.33
- STRS N/A
- AVG Volume (30 Days)
- ACHV 652.7K
- STRS 10.4K
- Earning Date
- ACHV 08-07-2025
- STRS 08-12-2025
- Dividend Yield
- ACHV N/A
- STRS N/A
- EPS Growth
- ACHV N/A
- STRS N/A
- EPS
- ACHV N/A
- STRS N/A
- Revenue
- ACHV N/A
- STRS $35,834,000.00
- Revenue This Year
- ACHV N/A
- STRS N/A
- Revenue Next Year
- ACHV N/A
- STRS N/A
- P/E Ratio
- ACHV N/A
- STRS N/A
- Revenue Growth
- ACHV N/A
- STRS N/A
- 52 Week Low
- ACHV $1.84
- STRS $15.10
- 52 Week High
- ACHV $5.31
- STRS $28.31
- Technical
- Relative Strength Index (RSI)
- ACHV 46.32
- STRS 52.31
- Support Level
- ACHV $2.37
- STRS $15.53
- Resistance Level
- ACHV $2.56
- STRS $17.30
- Average True Range (ATR)
- ACHV 0.12
- STRS 0.83
- MACD
- ACHV 0.01
- STRS 0.16
- Stochastic Oscillator
- ACHV 47.37
- STRS 75.00
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About STRS Stratus Properties Inc.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.